(PLX) - Earnings & Price History

PLX: - 0.756, $101.60M, -0.02 (-2.77%)

Sector: Healthcare - Industry: Biotechnology

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally. The company offers taliglucerase alfa for injection, which is marketed under the ELELYSO brand name, as an enzyme replacement therapy for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in Phase III clinical trial to treat Fabry diseases; PRX-110, a proprietary plant cell recombinant human Deoxyribonuclease 1 that is in Phase II clinical trial to treat cystic fibrosis; and OPRX-106, an oral anti TNF product candidate, which is in Phase II clinical trial for the treatment of ulcerative colitis. Protalix BioTherapeutics, Inc. wa

Past PLX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-16-0.111.221.21.151.111.23-4.17%▲6.09%1.67%3.35M
2015-08-04-0.081.691.671.681.651.70.60%0.60%1.20%54.95K
2015-08-03-0.081.671.721.721.671.74-2.91%-2.91%73.08K
2015-07-31-0.08
2015-07-30-0.081.641.591.621.621.681.89%1.23%3.14%49.06K
2015-07-29-0.081.591.651.681.571.681.82%-5.36%-3.64%152.31K
2015-07-21-0.081.751.771.771.751.81-1.13%-1.13%74.52K
2015-07-20-0.081.771.871.831.741.85-2.14%-3.28%-5.35%440.34K
2015-07-17-0.08
2015-07-16-0.081.891.911.941.871.941.57%-2.58%-1.05%35.93K
2015-07-15-0.081.911.921.91.91.97-1.04%0.53%-0.52%403.22K
2015-03-12-0.041.751.821.821.531.82-3.85%-3.85%147.56K
2014-11-20Protalix Biothr-0.01-0.092.092.112.12.052.13-0.47%-0.48%-0.95%216.40K
2014-08-14Protalix Biothr-0.072.722.722.72.682.8-0.74%0.74%493.00K
2014-05-22Protalix Biothr-0.07-0.083.833.853.823.763.86-0.78%0.26%-0.52%158.70K
2014-04-04Protalix Biothr-0.04-0.124.654.634.614.574.79-0.43%0.87%0.43%126.30K
2013-11-27Protalix Biothr-0.08-0.063.933.793.793.753.983.69%3.69%111.60K
2013-08-16Protalix Biothr-0.04-0.075.065.035.034.955.070.60%0.60%199.70K
2013-06-07Protalix Biothr-0.09-0.055.195.175.265.085.291.74%-1.33%0.39%279.20K
2012-11-29Protalix Biothr-0.09-0.065.555.65.675.445.671.25%-2.12%-0.89%341.50K
2012-08-31Protalix Biothr-0.15.165.435.295.165.35-2.58%-2.46%-4.97%205.40K
2012-05-24Protalix Biothr-0.1-0.076.286.086.096.066.290.16%3.12%3.29%203.60K
2012-02-28Protalix Biothr-0.15.345.425.45.345.5-0.37%▲-1.11%-1.48%262.40K
2011-08-10Protalix Biothr-0.084.454.494.364.254.6-2.90%2.06%-0.89%488.60K
2011-05-31Protalix Biothr-0.066.16.26.136.16.3-1.13%-0.49%-1.61%1.40M
2010-08-30Protalix Biothr-0.087.717.727.687.67.77-0.52%0.39%-0.13%289.80K
2010-03-02Protalix Biothr0.187.537.257.357.37.751.38%▲2.45%3.86%690.40K
2009-12-04Protalix Biothr-0.078.28.098.0288.32-0.87%2.24%1.36%1.12M
2009-08-28Protalix Biothr-0.086.45.9865.896.40.33%6.67%7.02%479.60K

Login | Register
Sunday Feb 18, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades